Lundin-CHUV Database

One of the Lundin Family Brain Tumour Research Centre's priorities is to provide research teams with the necessary infrastructure to support research projects and clinical trials. This includes the expansion of the CHUV’s existing Brain tumour biobank, which contains over 5,000 samples of all types of brain tumours. Dating back to 1999, it is one of the oldest in the world.

The biobank will be enriched with additional samples and advanced data from thousands of brain tumour patients over the next years. This will create an open-access, and importantly, a single comprehensive database that integrates diverse data, enabling researchers to identify unknown patterns and trends related to brain tumours.

The development of this ground-breaking data registry will immensely boost the scientific value of the biobank and pave the way for the development of more targeted and personalized treatments, improving patient outcomes and quality of life.

A well-designed and maintained database is crucial in ensuring the efficient and accurate management of data, including patient demographics, medical history, diagnostic test results, and treatment outcomes.

The database at the Lundin Family Brain Tumour Research Centre will collect clinical, radiological, and molecular information enabling the identification of markers that are common to a specific subgroup of patients. This approach can help predict the likelihood of a subgroup responding to a specific treatment, thereby providing them with more effective therapies, and may pave the way for future clinical trials.

The Centre will share this information and collaborate with esteemed institutions worldwide. It will thus contribute to the global effort to improve our understanding of brain tumours and develop more effective therapeutic approaches.

In addition, the Centre is committed to developing a state-of-the-art trusted research environment at the CHUV to enable researchers to access and analyze data in a secure and scalable IT infrastructure. It will also facilitate compliance with regulatory requirements.

The Lundin Family Brain Tumour Research Centre's work represents a significant step forward in the fight against brain tumours, providing researchers with a unique and comprehensive resource to gain new insights and accelerate clinical innovation.